Fingolimod Rebound: A Review of the Clinical Experience and Management Considerations
Abstract Because the treatment of multiple sclerosis (MS) may span decades, the need often arises to make changes to the treatment plan in order to accommodate changing circumstances. Switching drugs, or the discontinuation of immunomodulatory agents altogether, may leave patients vulnerable to rela...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2019-11-01
|
| Series: | Neurology and Therapy |
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1007/s40120-019-00160-9 |